Particle.news
Drug Efficacy Microbiome Research Patient Outcomes Epidemiology Genetic Research Pediatric Studies Patient Case Studies Cannabis Research Data Analysis Caffeine Studies Crossover Design Functional Imaging International Studies Fat Tissue Analysis Weight Loss Medications Lipid Research Cardiac Research Treatment Strategies U.K. Biobank Fasting Research Toxicology Research Gout Research Imaging Techniques Visual Acuity Obesity Phase 2 Trials Genetic Factors Predictive Biomarkers MRI Technology Pediatric Health Asthma Research Alzheimer's Disease Research Obesity and Kidney Disease Harvard University Heart Disease Studies Cardiovascular Research Participant Studies Dialysis Treatments Efficacy of Treatments Case Reports Traumatic Brain Injury Pain Relief Dietary Interventions FDA Approval Research Findings Patient Recruitment Treatment Development Cancer Treatment Vitamin D Effects Rehabilitation Techniques Dietary Impact Fertility Clinics Lipoprotein Studies Collaboration in Research Liver Damage Diagnosis Health Risks Sleep Apnea Vitiligo Fertility Treatments Pregnancy Complications Translational Medicine Magnesium and Hypertension Pediatric Neurology Therapeutic Applications Patient Care Hormone Therapy Body Composition Studies Immunotherapy Genetic Analysis Real-World Evidence Research Methodologies Liver Health Studies Chronotype Impact Therapeutics Human Intervention Studies Eli Lilly and Co. Cardiovascular Studies Heart Health Research Atherosclerosis Research
UCSF researchers linked epigenetic downregulation of interferon genes to symptom relief in older lupus patients, directing next steps toward age-stratified interferon blocker trials.
